BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jul 30, 2007
 |  BioCentury  |  Strategy

ESA sales

ESA sales

Combined sales of Aranesp darbepoetin alfa, Epogen epoetin alfa and Procrit epoetin alfa grew steadily - about 9% a year - from 2002 through 2006. But 2Q07 sales of ESAs from Amgen (AMGN) and Johnson & Johnson (JNJ) suggest this year could play out...

Read the full 222 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >